Quest Diagnostics shares are trading higher after the company announced it has launched consumer-initiated coronavirus antibody testing kits online. Morgan Stanley also upgraded the company stocks from Equal-Weight to Overweight and raised its price target from $95 to $139.
Benzinga Newsdesk